Literature DB >> 26925676

Determinants of Advanced Stage at Initial Diagnosis of Breast Cancer in Pakistan: Adverse Tumor Biology vs Delay in Diagnosis.

Samina Khokher1, Muhammad Usman Qureshi, Saqib Mahmood, Sadia Sadiq.   

Abstract

BACKGROUND: Breast cancer is the most frequent cancer of women in Pakistan with the majority presenting with stage III or IV lesionsat initial diagnosis. Patient and health system related factors are well known determinants of delay in presentation and diagnosis. Additionally, breast cancer being a heterogeneous disease, the various molecular subtypes featuring different aggressiveness also need to be considered. The present study evaluated the association of stage at initial diagnosis of breast cancer with these two factors in local women at a tertiary level health care facility in Lahore, Pakistan.
MATERIALS AND METHODS: Patient and tumor features were recorded separately during diagnostic workup in Breast Clinics at INMOL and at Services Hospital, Lahore. Data were entered in MS Excel and analyzed by descriptive statistics and Chi-Square test.
RESULTS: Among the 261 patients, 64% were staged as late breast cancer (LBC), the mean age was 46.8 with standard deviation of 13 years. Some 92% had invasive ductal carcinoma (IDC), 61% had luminal types (LT) of non-aggressive tumor while 39% had the non-luminal types (NLT) of of HER2-enriched or basal aggressive tumors. While 70% of patients presented within one year of symptomatic disease (early report group "ERG"), 30% reported after a mean delay of 4 years with a standard deviation of 3.75 years. The stage distribution among ERG patients was not statistically different from those reporting late (P=0.123). Statistically larger proportion of patients with NLT presented as LBC as compared to the LT (P =0.034). Among the ERG, statistically different stage distribution of disease was observed for the NLT versus LT (P=0.047). Among those presenting late, this difference was insignificant (P=0.416).
CONCLUSIONS: Breast cancer is a distinct disease in Pakistan with a high frequency of aggressive molecular types affecting younger women, with the majority presenting as LBC. Association of NLT with higher stage at diagnosis is statistically significant whereas time delay in diagnosis is not. Further research is required to define the risk profile and features in local patients. The burden of LBC can be reduced by promoting breast health awareness and by establishing easily accessible dedicated breast care set ups in the hospitals.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26925676     DOI: 10.7314/apjcp.2016.17.2.759

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Invasive Lobular Carcinoma in Premenopausal Woman: A Delayed Diagnosis Due to Socio-Cultural Factors Prevalent in Pakistan.

Authors:  Shafi Rehman; Jai Sivanandan Nagarajan; Bushra Ghafoor; Muhammad Hamza Qureshi; Shazmah Shahrukh
Journal:  Cureus       Date:  2022-05-05

2.  Patient Delay in Breast Cancer Diagnosis in Two Hospitals in Karachi, Pakistan: Preventive and Life-Saving Measures Needed.

Authors:  Uzma Shamsi; Shaista Khan; Iqbal Azam; Shaheryar Usman; Amir Maqbool; Tiffany Gill; Romaina Iqbal; David Callen
Journal:  JCO Glob Oncol       Date:  2020-06

3.  Identifying the reasons for delayed presentation of Pakistani breast cancer patients at a tertiary care hospital.

Authors:  Faisal Gulzar; Muhammad Shoaib Akhtar; Rafshan Sadiq; Sajid Bashir; Sajida Jamil; Shahid Mahmood Baig
Journal:  Cancer Manag Res       Date:  2019-01-29       Impact factor: 3.989

4.  Factors Associated With Treatment Delay in Breast Cancer: A Prospective Study.

Authors:  Raja Rahool; Ghulam Haider; Muhammad Hayat; Mehwish R Shaikh; Paras Memon; Bhunisha Pawan; Kiran Abbas
Journal:  Cureus       Date:  2021-02-09

Review 5.  Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review.

Authors:  Chukwudi A Nnaji; Elochukwu F Ezenwankwo; Paul Kuodi; Fiona M Walter; Jennifer Moodley
Journal:  BMJ Open       Date:  2022-02-04       Impact factor: 2.692

6.  Factors Influencing Total Delay of Breast Cancer in Northeast of China.

Authors:  Sihang Ren; Yuting Zhang; Pan Qin; Jia Wang
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

7.  Factors associated with Late-Stage Diagnosis of Breast Cancer among Egyptian Women.

Authors:  Horeya M Ismail; Samiha Mokhtar; Hazem El-Mansy
Journal:  J Public Health Res       Date:  2022-05-16

8.  CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer.

Authors:  Asim Pervaiz; Michael Zepp; Saqib Mahmood; Doaa Mohamed Ali; Martin R Berger; Hassan Adwan
Journal:  Cell Oncol (Dordr)       Date:  2018-11-19       Impact factor: 7.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.